» Articles » PMID: 34891154

Tumor Immune Microenvironment LncRNAs

Overview
Journal Brief Bioinform
Specialty Biology
Date 2021 Dec 10
PMID 34891154
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Long non-coding ribonucleic acids (RNAs) (lncRNAs) are key players in tumorigenesis and immune responses. The nature of their cell type-specific gene expression and other functional evidence support the idea that lncRNAs have distinct cellular functions in the tumor immune microenvironment (TIME). To date, the majority of lncRNA studies have heavily relied on bulk RNA-sequencing data in which various cell types contribute to an averaged signal, limiting the discovery of cell type-specific lncRNA functions. Single-cell RNA-sequencing (scRNA-seq) is a potential solution for tackling this limitation despite the lack of annotations for low abundance yet cell type-specific lncRNAs. Hence, updated annotations and further understanding of the cellular expression of lncRNAs will be necessary for characterizing cell type-specific functions of lncRNA genes in the TIME. In this review, we discuss lncRNAs that are specifically expressed in tumor and immune cells, summarize the regulatory functions of the lncRNAs at the cell type level and highlight how a scRNA-seq approach can help to study the cell type-specific functions of TIME lncRNAs.

Citing Articles

InfoScan: A New Transcript Identification Tool Based on scRNA-Seq and Its Application in Glioblastoma.

Mei S, Huang J, Zhang Z, Lei H, Huang Q, Qu L Int J Mol Sci. 2025; 26(5).

PMID: 40076844 PMC: 11900204. DOI: 10.3390/ijms26052208.


Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer.

Zhang J, Wei X, Xie Y, Peng S, Yang P, Chen Y Oncogene. 2025; .

PMID: 40044982 DOI: 10.1038/s41388-025-03323-1.


LncRNA LINC01128 promotes prostate cancer cell proliferation, metastasis, and epithelial-mesenchymal transition by modulating miR-27b-3p.

Zhao Y, Zhang Z, Zheng Y, Bai H, Wu X, Yang Y J Cancer Res Clin Oncol. 2025; 151(3):98.

PMID: 40035871 PMC: 11880183. DOI: 10.1007/s00432-025-06153-6.


LncRNA MSTO2P affects the proliferation, invasion and migration of non-small cell lung cancer by regulating the Wnt/β-catenin pathway.

Chen Y, Shi H, Dong Y, Cui W Discov Oncol. 2025; 16(1):150.

PMID: 39928213 PMC: 11811353. DOI: 10.1007/s12672-025-01920-w.


A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA.

Sun G, He L Front Immunol. 2025; 15:1498781.

PMID: 39916954 PMC: 11798941. DOI: 10.3389/fimmu.2024.1498781.


References
1.
Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

2.
Takahashi K, Yan I, Wood J, Haga H, Patel T . Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res. 2014; 12(10):1377-87. PMC: 4201956. DOI: 10.1158/1541-7786.MCR-13-0636. View

3.
Bhaduri A, Di Lullo E, Jung D, Muller S, Crouch E, Espinosa C . Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma. Cell Stem Cell. 2020; 26(1):48-63.e6. PMC: 7029801. DOI: 10.1016/j.stem.2019.11.015. View

4.
Krawczyk M, Emerson B . p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife. 2014; 3:e01776. PMC: 4017649. DOI: 10.7554/eLife.01776. View

5.
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z . LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013; 41(9):4976-87. PMC: 3643595. DOI: 10.1093/nar/gkt182. View